Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.


AIM To investigate risk factors for hepatocellular carcinoma (HCC) recurrence after living donor liver transplantation (LDLT) and efficacy of various criteria. METHODS From October 2000 to November 2011, 233 adult patients underwent LDLT for HCC at our institution. After excluding nine postoperative mortality cases, we analyzed retrospectively 224… (More)
DOI: 10.3748/wjg.v19.i29.4737


  • Presentations referencing similar topics